NovaBiotics

Blueberry Therapeutics

This clinical-stage biotechnology company develops nanomedicine therapies for patients with common dermatological and fungal infections using a proprietary delivery platform.

Amprologix

This biotechnology company develops novel antibiotics to treat antimicrobial-resistant bacterial infections for patients with conditions including MRSA and related skin and wound infections.

Arcutis Biotherapeutics

This biopharmaceutical company develops and commercialises topical treatments for patients with chronic inflammatory skin diseases such as psoriasis, eczema, and seborrhoeic dermatitis.

Nabriva

This biopharmaceutical company develops and commercialises novel antibiotics for patients with serious infections caused by drug-resistant bacteria.

Novogaia

This biotechnology company develops fungal-derived medicines and molecular structure decoding software for pharmaceutical researchers to treat autoimmune diseases.

DermBiont

This clinical-stage biotechnology company develops targeted topical therapeutics to treat skin diseases, such as hyperpigmentation and seborrheic keratoses, for patients with dermatological conditions.

Melinta Therapeutics

This biopharmaceutical company develops and commercialises antibiotics and antifungals to treat drug-resistant infections in hospital and clinic settings.

Discuva

This biotechnology company develops novel antibiotics to treat multi-drug resistant bacterial infections for pharmaceutical partners and healthcare providers.